- Sitagliptin/metformin, sold
under the
brand name
Janumet among others, is a fixed-dose
combination anti-diabetic
medication used to
treat type 2 diabetes...
-
available in the fixed-dose
combination medication sitagliptin/metformin (
Janumet,
Janumet XR).
Common side
effects include headaches,
swelling of the legs, and...
-
Jadenu Sprinkle Jadenu Jaimiess Jakafi Jalyn Jamteki Janimine Jantoven Janumet XR
Janumet Januvia Jardiance Jatenzo Jayln Jaypirca Jeanatope Jelmyto Jemperli...
-
inhibitors combined with
metformin include a sitagliptin/metformin
combination (
Janumet), a saxagliptin/metformin
combination (Kombiglyze XR, Komboglyze), and...
-
combination drug
containing both
Januvia and
metformin under the
trade name
Janumet.
There has been some
concern that
treatment with
Januvia and
other DPP-IV...
-
Raltegravir 248,924 0.72%
Merck & Co., Inc. HIV
Infection Dec-1998 Mon-20XX 62
Janumet Sitagliptin/metformin 247,150 4.65%
Merck & Co., Inc.
Diabetes mellitus...
-
arthritis Merck $377.3 $329.1 $265.4 $218.2 sitagliptin/metformin HCl
Janumet Type 2
diabetes Merck $351.1 $86.4
finasteride Proscar Benign prostatic...
- team for the project. The drug was
approved by the FDA in
October 2006.
Janumet™, a drug
combining sitagliptin and
metformin was also approved, in April...
- team for the project. The drug was
approved by the FDA in
October 2006.
Janumet, a drug
combining sitagliptin and
metformin was also approved, in April...
